Precipio, Inc. Common Stock

PRPONASDAQUSD
23.44 USD
0.05 (0.19%)🟢PRE MARKET (AS OF 04:01 AM EDT)
🟢Market: OPEN

Shares of Precipio, Inc. Common Stock (PRPO) are trading at $23.44. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, PRPO appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Aug 6, 2026.

Open?$23.44
High?$23.44
Low?$23.44
Prev. Close?$23.48
Volume?3
Avg. Volume?86.1K
VWAP?$23.44
Rel. Volume?0.00x
Bid / Ask
Bid?$18.92 × 100
Ask?$28.41 × 100
Spread?$9.49
Midpoint?$23.67
Valuation & Ratios
Market Cap?41.9M
Shares Out?1.8M
Float?1.6M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?2.96
EPS?-$0.52
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Employees
71
Market Cap
41.9M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2000-07-18
Address
4 SCIENCE PARK
NEW HAVEN, CT 06511
Phone: 203 787 7888
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
75
Short Sent.?
90
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.12Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.60%Low
Short Interest?26.4K
Days to Cover?1.0
Free Float1.6M
Avg Daily Volume84.7K
Settlement Date2026-07-15
Financial Health
Current Ratio?1.56Adequate
Quick Ratio?1.33Adequate
Cash Ratio?0.68Adequate
Debt/Equity?0.07Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
87/100
P/E?
N/A
P/B?
Peers
100
S&P
56
2.96CHEAP
P/S?
Peers
100
S&P
77
1.59CHEAP
P/FCF?
Peers
100
S&P
3
75.6PRICEY
EV/EBITDA?
S&P
97
-66.6CHEAP
EV/Sales?
Peers
100
S&P
83
1.53CHEAP
Returns & Efficiency
ROE?
S&P
10
-6.5%WEAK
ROA?
S&P
3
-4.4%WEAK
Cash Flow & Enterprise
FCF?$555.0K
Enterprise Value?$40.3M
Fundamentals ratios updated end of day